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Abstract
Myocardial infarction (MI) is the most serious manifestation of coronary artery disease and the cause of significant mortality
and morbidity worldwide. Galectin-1(GAL-1), a divalent 14.5-kDa protein, is present both inside and outside cells, and has
both intracellular and extracellular functions. Hypoxia inducible factor-1 alpha (HIF-1a) is a transcription factor mediating
early and late responses to myocardial ischemia. Identification of the pattern of expression of GAL-1 and HIF-1a in the heart
during the first 24 hours following acute MI will help in understanding early molecular changes in this event and may
provide methods to overcome serious complications. Mouse model of MI was used and heart samples were processed for
immunohistochemical and immunofluorescent labeling and Enzyme linked immunosorbent assay to identify GAL-1 and HIF
1a levels in the heart during the first 24 hours following MI. There was significant increase in left ventricular GAL-1 at 20
(p = 0.001) and 30 minutes (p = 0.004) following MI. There was also a significant increase in plasma GAL-1 at 4 hours
(p = 0.012) and 24 hours (p = 0.001) following MI. A significant increase in left ventricular HIF-1 a was seen at 20 minutes
(p = 0.047) following MI. In conclusion, we show for the first time that GAL-1 level in the left ventricle is increased in early
ischemic period. We also report for the first time that HIF-1 a is significantly increased at 20 minutes following MI. In
addition we report for the first time that mouse plasma GAL-1 level is significantly raised as early as 4 hours following MI.
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Introduction
Myocardial infarction (MI) is the most dreaded but likely
manifestation of coronary artery disease, which is the cause of
significant mortality and morbidity worldwide. Early diagnosis and
timely intervention have improved outcomes and remains the
cornerstone of therapy for acute MI. Understanding the very early
changes that the myocardium undergoes following an ischemic
event is the key to devising ways that will ultimately enable
diagnosing a cardiac ischemic event before it has caused significant
damage to the heart.
Galectins are a family of b-galactoside-binding lectins [1].
Fifteen members have been identified and are found to be widely
distributed from lower invertebrates to mammals [2,3]. Galectin-1
[GAL-1] is a prototypical member of the galectin family of lectins.
It is a divalent 14.5-kDa protein characterized by one carbohy-
drate recognition domain (CRD) that can occur as a monomer or
as a non-covalent homodimer consisting of subunits of one CRD
[1,4]. GAL-1 is produced by a variety of vascular, interstitial,
epithelial, and immune cells [5–8]. GAL-1 is present both inside
and outside cells, and has both intracellular and extracellular
functions. The extracellular functions require the carbohydrate-
binding properties while the intracellular ones are associated with
protein-protein interactions [4]. GAL-1 forms lattice-like com-
plexes with receptors that participate in recognition of cell-matrix
[9–12]. GAL-1 lacks recognizable secretion signal sequences and
does not pass along the standard endoplasmic reticulum/Golgi
pathway [13]. GAL-1 is secreted through the non-classical
pathway via inside-out transportation involving direct transloca-
tion across the plasma membrane and requiring unidentified
integral membrane proteins and cytosolic factors [14]. In the
extracellular compartment GAL-1 regulates cell-cell and cell-
matrix interactions, the immune response, apoptosis, and
neoplastic transformation. In the intracellular compartment it
regulates cell cycle, RNA splicing and transcription [12,15–19].
Intracellular GAL-1 has been shown to be present in cells nuclei
and cytosols [4]. Although GAL-1 is involved in very important
functions in vitro and in vivo, GAL-1 null mice are viable
indicating that its presence is not critical for mammalian
development or survival [11].
Studies have identified GAL-1 as hypoxia-induced protein. The
hypoxic regulation of GAL-1 at mRNA and protein levels has
been demonstrated in tumor biology and has the potential to be
used as a prognostic marker of malignancy [20]. Under hypoxic or
ischemic conditions in the brain either in vitro or in vivo, GAL-1
was found to inhibit the proliferation of astrocytes and attenuate
astrogliosis. GAL-1 treatment reduced apoptosis of neurons,
decreased brain infarction volume and improved neurological
function induced by the ischemia, making GAL-1 a potential
therapeutic target for attenuating neuronal damage and promot-
ing recovery of brain ischemia [21]. Studies have shown that in
lung tissue; the expression of GAL-1 is diffusely distributed
throughout the interstitium and near to the basement membrane
of vessels and airways in both normal and hypoxia-exposed mice.
The difference was that the intensity of GAL-1 staining was
increased in hypoxia-exposed mice, which suggest that GAL-1
may be important in adaptive responses of murine lung to chronic
hypoxia [22]. The above-mentioned studies have shown that
GAL-1 is regulated by hypoxia but its exact mechanism remains
elusive.
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Recently, Zhao et al [23] has demonstrated that hypoxia
inducible factor- 1a (HIF- 1a) significantly increases GAL-1
expression in messenger RNA and protein levels in four colorectal
cancer cell lines and it has been proposed that GAL-1 gene is a
direct target of transcriptional factor HIF-1 a [22,23]. HIF-1a
itself is a transcription factor mediating early [24] as well as late
responses to myocardial ischemia [25].
In the present study, we investigated if there is any change in the
endogenous production of GAL-1 in early ischemia and its pattern
of expression in the ischemic and non-ischemic cardiomyocytes.




Male C57B6/J mice were divided into 5 groups with the
following time points: Group I: 20 minutes post MI (n = 8), Group
II: 30 minutes post MI (n = 8), Group III: 60 minutes post MI
(n = 8), Group IV: 4- hour post MI (n = 8) and Group V: 24- hour
post MI (n = 8). Samples from sham operated animals, which are
our controls, (20 minutes sham n = 7, 30 minutes sham n = 7, 60
minutes sham n = 7, 4- hour sham n = 7 and 24- hour sham n = 7)
for each mentioned time points were also studied. Samples from
non-operated normal animals (Naı̈ve n = 7) were also studied.
Another separate group for 20 min MI (n = 6) and sham-operated
animals (n = 6) were also studied.
Ethical Approval
The Animal Research Ethics Committee of the College of
Medicine and Health Sciences, UAE University have approved all
experimental procedures; Protocol No.A12/10.
Murine Model of Myocardial Infarction
All experiments were performed with the guidelines for the
‘Principles of Laboratory Animal Care’ and the ‘Guide for the care
and use of laboratory animals’ published by NIH (NIH
Publication No. 85-23, revised 1996), and specific national laws
have been observed. C57B6/J mice (male, age: 12–16 weeks; wt:
20–25 g) were anesthetized by an intraperitoneal injection of a
combination of Ketamine (100 mg/kg) and Xylazine (10 mg/kg).
The mice were then intubated by transesophageal illumination
using a modified 22-gauge plastic cannula and fixed on the
operating pad in the supine position by taping all four extremities.
The mice were connected to a mouse ventilator (Harvard
apparatus Minivent Hugo Sachs Electronik) which supplied room
air supplemented with 100% oxygen (tidal volume 0.2 ml/min.,
rate 120 strokes/min). Rectal temperature was continuously
monitored and maintained within 36–37uC using a heat pad.
The lead II ECG (ADInstrument multi-channel recorder inter-
faced with a computer running Power lab 4/30 data acquisition
software) was recorded from needle electrodes inserted subcuta-
neously. Myocardial infarction was induced in the mice by
permanently occluding the left anterior descending coronary
(LAD) artery as described earlier [26–28].
Briefly, the chest was opened with a lateral incision at the 4th
intercostal space on the left side of the sternum. Next the chest wall
Figure 1. Electrocardiography of the heart at 20 minutes, 30 minutes, 60 minutes, 4-hour and 24-hour following MI. Representative
ECG of 20 minutes, 30 minutes, 60 minutes, 4 hours and 24 hours post MI groups showing ST elevation compared to normal ECG in sham operated
groups.
doi:10.1371/journal.pone.0086994.g001
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Figure 2. Left ventricular galectin-1 and HIF-1 a concentration and plasma concentration of galectin-1 following MI. A. The graph
represents HIF-1 a concentrations at 20 min, 30 min, 60 min, 4 hours and 24 hours post myocardial infarction with corresponding sham operated
groups in C57BL6 mouse left ventricle. Control represents non-operated normal animal heart. *Shows p,0.05. B. HIF-1 a levels in nuclear and
cytoplasmic extracts of LV mouse heart at 20 minutes following MI. *Shows p,0.05. C. The graph represents left ventricular galectin-1 concentrations
at 20 min, 30 min, 60 min, 4 hours and 24 hours post myocardial infarction with corresponding sham operated groups in C57BL6 mouse heart.
Control represents non-operated normal animal heart. *Shows p,0.05. D. The graph represents ratio of plasma galectin-1 concentration in
myocardial infarction to plasma galectin-1 concentration in sham operated mice C57BL6 mice. 4 hours and 24 hours post myocardial infarction show
significant difference from sham operated mice. *Shows p,0.05. E. Pattern of Galectin-1 and HIF-1 a in the heart from 20 min post MI till 24 hour
post MI time points, showing similar pattern of expression during the first 24-hour following MI.
doi:10.1371/journal.pone.0086994.g002
Galectin-1 in Early Myocardial Infarction
PLOS ONE | www.plosone.org 3 January 2014 | Volume 9 | Issue 1 | e86994
was retracted for better visualization of the heart. With minimal
manipulation, the pericardial sac was removed and the left
anterior descending artery (LAD) was visualized with a stereomi-
croscope (Zeiss STEMI SV8). An 8-0 silk suture was passed under
the LAD and ligated 1 mm distal to left atrial appendage.
Occlusion was confirmed by observing immediate blanching of the
left ventricle (LV) post ligation. An accompanying ECG recording
showed characteristic ST-elevation, which further confirmed
ischemia. The chest wall was closed by approximating the third
and fourth ribs with one or two interrupted sutures. The muscles
returned back to their original position and the skin closed with 4-
0 prolene suture. The animal was gently disconnected from the
ventilator and spontaneous breathing was seen immediately.
Postoperative analgesic (Butorphanol 2 mg/kg, s/c, 6 hourly)
was given at the end of the procedure. Sham operated mice
underwent exactly the same procedure described above, except
that the suture passed under the LAD is left open and untied.
Sham operated mice groups are our control and they exactly
follow the same time points of corresponding MI groups.
According to the experimental protocol, mice were sacrificed
after induction of myocardial infarction with desired time of
ischemia. The method of euthanasia started with intraperitoneal
injection of anesthetic drugs, which included a combination of
Ketamine (100 mg/kg) and Xylazine (10 mg/kg). When the
mouse was completely anesthetized, skin and chest wall were re-
opened. Blood was collected in EDTA vacutainers and the heart
was resected, washed in ice cold phosphate buffered saline (PBS),
the right ventricle and both atria were dissected away and LV was
immediately frozen in liquid nitrogen and later stored in 280uC
freezer. Collected blood was centrifuged at 3000 RPM for 15
minutes. The plasma was collected, alliquoted and stored at
280uC until further analysis. Heart samples from the same time
point following LAD ligation were also fixed in 10% buffered
formal-saline for 24 hours.
Sample Processing for Protein Extraction
Total protein was extracted from heart samples by homogeniz-
ing with lysis buffer and collecting the supernatant after
centrifugation. For total cell lysate, the left ventricular heart along
with the septum samples were thawed, weighed and put in cold
lysis buffer containing 50 mM Tris, 300 mM NaCl, 1 mM MgCl2,
3 mM EDTA, 20 mM b-glycerophosphate, 25 mM NaF, 1%
Triton X-100, 10%w/v Glycerol and protease inhibitor tablet
(Roche Complete protease inhibitor cocktail tablets). The hearts
were homogenized on ice by a homogenizer (IKA T25 Ultra
Turrax). The samples were then centrifuged at 14000 RPM for 15
minutes at 4 o C, supernatant collected, alliquoted and stored at
280uC until further analysis. Nuclear and cytoplasmic protein
extraction was done following the protocol described elsewhere
[29]. Briefly, the heart LV were thawed on ice, weighed and
homogenized on ice with buffer containing Tris HCl 10 mmol/l,
CaCl2 3 mmol/l, MgCl2 2 mmol/l, EDTA 0.1 mmol/l, Phenyl-
methanesulfonyl fluoride (PMSF) 0.5 mmol/l, Sucrose
0.32 mmol/l, Dithiothreitol (DTT) 1 mmol/l, Nonidet P-40
(NP-40) 0.5% and Protease inhibitor cocktail 1%. The homoge-
nates were centrifuged at 800 g for 10 minutes. The supernatant
removed and kept as cytoplasmic fraction. The pellet was washed
twice with homogenization buffer without NP-40 and resuspended
with a low salt buffer containing HEPES 20 mmol/l, MgCl2
1.5 mmol/l, KCl 20 mmol/l, EDTA 0.2 mmol/l. Glycerol 25%,
PMSF 0.5 mmol/l and DTT 0.5 mmol/l. After incubation on ice
for 5 minutes, an equal volume of high salt buffer containing
HEPES 20 mmol/l, MgCl2 1.5 mmol/l, KCl 800 mmol/l, EDTA
0.2 mmol/l. Glycerol 25%, PMSF 0.5 mmol/l, DTT 0.5 mmol/l,
NP-40 1% and protease inhibitor cocktail 1%, was added, the
mixture incubated on ice for 30 minutes, centrifuged at 14000 g
for 15 minutes at 4uC and supernatants saved as the nuclear
fraction. Total protein concentration was determined by BCA
protein assay method (Thermo Scientific Pierce BCA Protein
Assay Kit).
Sample Processing for Histology
Hearts were excised, washed with ice-cold PBS and weighed.
Each heart was sectioned, cassetted and fixed directly in 10%
buffered formalin. Sections were dehydrated in increasing
concentrations of ethanol, cleared with xylene and embedded
with paraffin. Three-mm sections were prepared from paraffin
Table 1. HIF-1 a levels in pg/mg of total protein at different








Naive 7 31.97 5.78 2.18
20 min MI 8 95.49 35.09 12.41 0.047*
20 min sham 7 65.58 1.86 0.70
30 min MI 8 36.34 7.39 2.62 0.103
30 min sham 6 30.54 3.47 1.42
60 min MI 8 40.85 12.98 4.59 0.904
60 min sham 7 40.01 13.61 5.15
4- hour MI 8 59.35 9.12 3.22 0.421
4- hour sham 7 54.98 11.28 4.26
24 hour MI 7 40.75 6.89 2.61 0.123
24-hour sham 7 46.65 6.41 2.42
*shows p,0.05.
doi:10.1371/journal.pone.0086994.t001
Table 2. HIF-1 a levels in pg/mg total protein in nuclear and cytoplasmic fractions of left ventricular heart tissue at 20 min post
myocardial infarction.
HIF-1a (LV) Groups Number Mean Std. Deviation Std. Error P value
Nuclear fraction pg/mg 20 min MI 6 87.05 13.24 5.41 0.032*
20 min Sham 6 70.75 9.11 3.72
Cytoplasmic fraction pg/mg 20 min MI 6 38.16 3.60 1.47 0.125
20 min Sham 6 34.11 4.70 1.92
*shows p,0.05.
doi:10.1371/journal.pone.0086994.t002
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blocks and stained with haematoxylin and eosin. The stained
sections were evaluated by the histopathologist that participated in
this project.
Immunohistochemistry. Five- mm sections were cut, de-
waxed with xylene and rehydrated with graded alcohol. The slides
were then placed in a 0.01 M citrate buffer solution (pH = 6.0) and
pre-treatment procedures to unmask the antigens was performed
in a microwave oven for 10 minutes. Sections were treated with
peroxidase and protein block for 60 min each and then incubated
overnight with anti- GAL-1 (rabbit anti-mouse polyclonal
antibody 1:2500, Davids Biotechnologie GmbH, Germany), anti-
HIF 1 a (rabbit anti-mouse polyclonal antibody 1:300, Davids
Biotechnologie GmbH, Germany), anti-cleaved caspase 3(Rabbit
polyclonal, ASP 175, Cell Signaling Technology, USA), anti-Bcl2
(Mouse monoclonal,SP66,Cell Marque, USA )and anti-ki67
(Rabbit monoclonal, SP6, Cell Marque, USA) antibodies at 4uC.
After conjugation with primary antibodies, sections were incubat-
ed with biotin-labeled secondary antibody (Thermo Scientific,
USA) for 20 minutes at room temperature. Finally, sections were
incubated with streptavidin–peroxidase complex for 20 minutes at
room temperature (Thermo Scientific, USA), DAB chromogen
(Thermo Scientific, USA) added and counter staining done with
haematoxylin. Appropriate positive controls were used. For
negative control, the primary antibody was not added to sections
Figure 3. HIF-1 a expression of the heart. A. Representative section of naı̈ve heart showing nuclear expression of HIF-1 a by few endothelial cells
(arrow head), streptavidin- biotin immunoperoxidase method. B. Negative control section showing no HIF-1 a staining, streptavidin- biotin
immunoperoxidase method. C. Positive control section of mouse placenta showing nuclear staining of HIF-1 a by trophoblastic cells, Rhodamine,
immunofluorescent technique. D. Negative control section for HIF-1 a. Rhodamine, immunofluorescent technique. E,I,M&Q shows representative
sections from the anterior wall of left ventricle in the area supplied by LAD 20 min, 30 min, 60 min and 4 hours following ligation of LAD, showing
variable nuclear staining of HIF-1 a by cardiac myocytes at different time points (arrow head) and endothelial cells (thin arrow), streptavidin- biotin
immunoperoxidase method. F,J,N&R shows their corresponding Sham operated hearts showing low nuclear expression of HIF-1 a by few endothelial
cells (thin arrow), streptavidin- biotin immunoperoxidase method. Low and high power views of the left ventricle 20 min (G&H), 30 min (K&L), 60 min
(O&P) and 4 hours (S&T) following ligation of LAD showing high nuclear staining of HIF-1 a by cardiac myocytes (arrow head), Rhodamine,
immunofluorescent technique.
doi:10.1371/journal.pone.0086994.g003
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and the whole procedure carried out in the same manner as
mentioned above.
Immunofluorescent labeling. 5 mm sections were depar-
affinized with xylene and rehydrated with graded alcohol. Sections
were placed in EnVisionTM FLEX Target Retrieval Solution with
Figure 4. Galectin-1 and HIF-1 a expression 24 hours following ligation of LAD. A. A high power view of left ventricle in an area supplied by
LAD showing coagulative necrosis (thin arrows) accompanied by heavy neutrophil polymorphs infiltration (arrow heads), H&E. B. A low power view of
the heart showing areas of high expression of galectin-1 (thick arrows) surrounding areas of no expression (star shape) in the left ventricle and
interventricular septum in the area supplied by LAD, streptavidin- biotin immunoperoxidase method. C. Sham operated heart showing lower
expression of galectin-1 in the left ventricle and right ventricle (thick arrows), streptavidin- biotin immunoperoxidase method. D. Negative control
section of the heart showing absence of staining of galectin-1. E, F&G. Representative section of the left ventricle from area supplied by LAD showing
high cytoplasmic expression of galectin-1 by cardiac myocytes (thick arrow), surrounding areas of no expression (thin arrow). Many neutrophil
polymorphs are also showing cytoplasmic expression of Galectin-1(arrow head), Streptavidin- biotin immunoperoxidase method. H, I&J.
Representative section from left ventricle showing a well demarcated area of high cytoplasmic expression of galectin-1 by cardiac myocytes (thick
arrow) surrounding areas of no expression (thin arrow), many neutrophil polymorphs (arrow head) show cytoplasmic expression of Galectin-1, Alexa
Fluor 488 immunofluorescent technique. K. Representative section from left ventricle showing nuclear expression of HIF-1 a by cardiac myocytes
(arrow head) and neutrophil polymorphs (thin arrow), Rhodamine, immunofluorescent technique. L. Representative section from left ventricle
showing cytoplasmic expression of Galectin-1 by cardiac myocytes (thick arrow), endothelial cells (arrow head) and neutrophil polymorphs (thin
arrows), Alexa Fluor 488 immunofluorescent technique. M. Co-localization of Galectin-1 and HIF-1 a in cardiac myocytes (thick arrow), endothelial cell
(arrow head) and neutrophil polymorphs (thin arrow), Alexa Fluor-Rhodamine immunofluorescent technique.
doi:10.1371/journal.pone.0086994.g004
Galectin-1 in Early Myocardial Infarction
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a high PH (PH 9) (DAKO Cytomation, Denmark) in a water bath
at 80uC for one hour. Later they were incubated with anti-HIF-1a
(rabbit anti-mouse polyclonal antibody, Davids Biotechnologie
GmbH, Germany), anti-GAL-1 (rabbit anti-mouse polyclonal
antibody, Davids Biotechnologie GmbH, Germany), and anti-
caspase-3(Rabbit polyclonal, (CPP32) Ab-4, Thermo ScientificTM
Lab Vision, USA) overnight at room temperature. Sections were
subsequently incubated with Donkey anti-rabbit Ig conjugated-
Rhodamine (Santa Cruz Biotechnology, USA, 1:50), or with
donkey anti-rabbit Alexa Fluor 488, (Invitrogen, USA, 1:50).
Finally, sections were mounted in water-soluble mounting media
and viewed with Olympus Fluorescent microscope. Immunofluo-
rescent double labeling for GAL-1 with HIF-1a, desmin, CD31,
CD68, and HIF-1a, with CD31 and CD 68 were done on heart
sections in the same way as described above. The first primary
antibody is labeled with fluorescein; the second primary antibody
is added afterwards followed by fluorescein label with different
excitation color. Appropriate positive control sections were used.
For negative control, the primary antibody was not added to
sections and the whole procedure carried out in the same manner
as mentioned above.
Morphometric analysis. Morphometric analysis of GAL-1
and HIF-1 a expression in cardiomyocytes, endothelial cells and
Table 3. Galectin-1 levels in ng/mg of total protein at








Naive 7 66.32 12.39 4.69
20 min MI 8 148.91 18.81 6.65 0.001*
20 min sham 8 117.20 12.57 4.45
30 min MI 8 117.45 9.88 3.49 0.004*
30 min sham 7 101.79 6.97 2.63
60 min MI 8 100.43 8.63 3.05 0.208
60 min sham 7 94.99 7.29 2.75
4 -hour MI 8 97.01 9.36 3.31 0.224
4- hour sham 7 91.07 8.63 3.26
24- hour MI 8 75.71 10.94 3.87 0.079
24 -hour sham 6 85.24 5.92 2.42
*shows p,0.05.
doi:10.1371/journal.pone.0086994.t003
Figure 5. Galectin-1 expression in naı̈ve heart. I, Naı̈ve heart, A. Low power view of the heart showing the left ventricle (arrow head),
interventricular septum (thick arrow) and right ventricle wall (thin arrow), H&E stain. B&C are representative sections of the left and right ventricles
respectively, H&E stain. D. showing low and focal expression of galectin-1 in the wall of the right ventricle (thin arrow) and the interventricular septum
(thick arrow). E. A representative section of left ventricle showing mild expression of galectin-1 by endothelial cells (arrow head). F. A representative
section of right ventricle showing low cytoplasmic expression of galectin-1 by cardiac myocyte (arrow head) and endothelial cells (thin arrow). G, H&I,
immunofluorescent labeling of sections of the heart showing a net-like pattern of galectin-1 staining of cardiac myocytes (thin arrow) and
cytoplasmic staining of endothelial cells (arrow head).
doi:10.1371/journal.pone.0086994.g005
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neutrophil polymorphs was done at different time points following
ligation of LAD using ImageJ software (http://rsbweb.nih.gov/ij/
). GAL-1 labeling was determined by counting the number of
cardiomyocytes, endothelial cells and neutrophil polymorphs in 10
randomly-selected fields in the left ventricle. For GAL-1 labeling,
cells were considered positive when there was a cytoplasmic and/
or nuclear staining pattern. The labeling index for cardiomyocytes,
endothelial cells and neutrophils were expressed as the percentage
of labeled cells against the total number of cell enumerated. For
HIF-1 a labeling, cells were considered positive when there was a
nuclear staining pattern. The labeling index for cardiomyocytes,
endothelial cells and neutrophils were expressed in the same way
as done for GAL-1. Neutrophil polymorphs were counted only in
24h post MI time point.
Enzyme Linked Immunosorbent Assay
Left ventricular myocardial concentration of GAL-1 and HIF-1
a and plasma levels of GAL-1 was determined using DuoSet
enzyme linked immunosorbent assay (ELISA) Development kit
(R&D Systems, Minneapolis, MN, USA) for sandwich ELISA,
using standard procedure according to the manufacturer’s
instructions. The levels were normalized to total protein concen-
trations.
Briefly, 96-well plates (Nunc-Immuno Plate MaxiSorp Surface
(NUNC Brand Products, A/S, Roskilde, Denmark), were coated
with antibody specific for GAL-1 and HIF-1 a. Biotinylated
detection antibody and streptavidin conjugated horseradish
peroxidase were used for detection of captured GAL-1 and HIF-
1 a. Captured GAL-1 and HIF-1 a were visualized using
tetramethylbenzidine (TMB)/hydrogen peroxide. Absorbance
readings were made at 450 nm, using a 96-well plate spectropho-
Figure 6. Galectin-1 expression 20 minutes following ligation of LAD. A. A low power view of the heart showing a high expression of
galectin-1 in the anterior wall of left ventricle in the area supplied by LAD (thin arrow) and the interventricular septum (thick arrow). There is also
increase in the expression of galectin-1 in the right ventricle (arrow head), streptavidin- biotin immunoperoxidase method. B. Sham operated heart
showing lower expression of galectin-1 in the left ventricle and right ventricle (thin arrow), streptavidin- biotin immunoperoxidase method. C.
Negative control section of the heart showing absence of galectin-1 staining. D, E&F. Representative sections of the left ventricle from area supplied
by LAD showing high cytoplasmic expression of galectin-1 by cardiac myocytes (thin arrow D). High power views show a well demarcated area of
high cytoplasmic expression of galectin-1 by cardiac myocytes (thin arrow) and endothelial cells (arrow head, E&F), There is also nuclear expression of
galectin 1 by cardiac myocytes (thick arrow E&F),streptavidin- biotin immunoperoxidase method. G, H&I. Representative section from left ventricle
shows a well demarcated area of high cytoplasmic expression of galectin-1 by cardiac myocytes (thin arrow).There is also high expression of galectin-
1 in the Z bands (arrow head), Alexa Fluor 488 immunofluorescent technique.
doi:10.1371/journal.pone.0086994.g006
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tometer (BioTek ELx800). GAL-1 and HIF-1 a levels in samples
were determined by interpolation from a standard curve.
Bioinformatic Analysis
We used the bioinformatic analysis program Clustalw2 available
on the Internet (http://www.ebi.ac.uk/Tools/msa/clustalw2/) to
find out the core HIF-binding motif ‘RCGTG’, the Hypoxia
response element (HRE) [30] in the promoter region of the mouse
and human GAL-1 gene.
Statistical Analysis
Statistical analysis is done using IBM SPSS Statistics version 20.
Data are presented in mean 6 S.E. Statistically significant
differences (p,0.05) are calculated between acute MI group and
corresponding sham-operated group for each time point by
Student t test. One-way ANOVA is used to test for differences
among the various time points within the MI groups. Chi square
test is used to assess differences in the expression of GAL-1 and
HIF-1 a in cardiomyocytes & endothelial cells at different time
points following MI for morphometric analysis.
Results
Electrocardiographic Study
The ECG records for mice groups; 20 minutes, 30 minutes, 60
minutes, 4 hours and 24 hours following permanent ligation of
LAD show persistent ST elevations. The ECG for 20 min, 30 min
and 60 min post LAD ligation groups were monitored for the
whole duration of time whereas for 4 hours and 24 hours post MI
groups it was monitored for the first 15 minutes (Fig. 1). We have
used persistent elevation of ST- segment in the ECG as a control
for selection of animals to be included in our study.
HIF-1 a in Heart Tissue
HIF-1 a concentration in LV tissue of naı̈ve group is
31.9762.18 pg/mg. HIF-1 a protein concentration shows a
significant increase in the LV at 20 minutes following MI group
compared to sham operated control group (95.5612.4 vs
65.660.7 pg/mg, P=0.047*) (Table 1) (Fig. 2 A). HIF-1 a
values in the MI groups are higher than corresponding sham
operated groups at 30 minutes, 60 minutes and 4-hour groups but
show no statistical significance (36.3462.62 vs 30.5461.42 pg/
mg, 40.8564.6 vs 40.0165.15 pg/mg, and 59.3563.22 vs
Figure 7. Galectin-1 expression 30 minutes following ligation of LAD. A. A low power view of the heart showing a high expression of
galectin-1 in the anterior wall of left ventricle in the area supplied by LAD (thin arrow) and the interventricular septum (thick arrow). There is also
increase in the expression of galectin-1 in the right ventricle (arrow head), streptavidin- biotin immunoperoxidase method. B. Sham operated heart
showing lower expression of galectin-1 in the left ventricle and right ventricle (thin arrow), streptavidin- biotin immunoperoxidase method. C.
Negative control section of the heart showing absence of staining of galectin-1. D. A galectin-1 positive control section from prostate gland showing
cytoplasmic expression of galectin- 1 by prostatic acini. E, F & G. Representative sections of the left ventricle from areas supplied by LAD showing
high cytoplasmic expression of galectin-1 by cardiac myocytes (thin arrow), streptavidin- biotin immunoperoxidase method. H, I&J. Representative
sections from left ventricle showing a well demarcated area of high cytoplasmic expression of galectin-1 by cardiac myocytes (thin arrow), Alexa Fluor
488 immunofluorescent technique.
doi:10.1371/journal.pone.0086994.g007
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54.9864.26 pg/mg,). The 24-hour HIF-1 a level in sham-
operated group appears to be higher than the MI group but does
not reach statistical significance (46.6562.42 vs 40.7562.61 pg/
mg). HIF-1 a value in LV in all MI groups is higher than the
baseline naı̈ve control group.
The pattern of HIF-1 a protein expression in the LV after
permanent ligation of LAD shows a transient significant peak at 20
minutes following MI, which goes down afterwards but still
remains high compared to the naı̈ve control animal group
(Table 1) (Fig. 2A).
As we observed a peak of HIF-1 a at 20 minutes post MI time
point, so we did a separate experiment for 20 minutes time point
to measure the HIF-1 a concentration in the nuclear and
cytoplasmic extracts of the LV. The results show a significant
rise of HIF-1 a concentration in the nuclear extract of the MI
group compared to the sham operated group (87.8465.41 vs
70.7563.72 pg/mg, p=0.03*) (Table 2) (Fig. 2 B).
There was a statistically significant difference between the
different time points within the MI groups as determined by one-
way ANOVA (F (4,34) = 14.672, p= .000). Tukey post-hoc test
showed that the 20 min post MI HIF-1 a level (M = 95.48, 95%
CI [66.15, 24.82]) is significantly higher than 30 minutes
(M = 36.34, 95% CI [30.15, 42.53], p= 0.00), 60 minutes
(M = 40.85, 95% CI [30.00, 51.7], p= 0.00), 4 hours(M = 59.35,
95% CI [51.72, 66.98], p= 0.003), and 24 hours post MI group
(M = 40.75, 95% CI [34.37, 47.13], p= 0.00).
The expression of HIF-1a is predominantly seen in the nuclei of
endothelial cells (Fig. 3 A) in the naı̈ve heart. The expression of
HIF-1 a in the nuclei of cardiomyocytes is very low and in few cells
in naı̈ve heart. There is a higher nuclear expression of HIF-1 a by
cardiac myocytes and endothelial cells in the area supplied by
LAD artery at 20 (Fig. 3 E, G, H) and 30 minutes (Fig. 3 I, K,
L), groups when compared with 60 minute (Fig. 3 M, O, P), 4
hours (Fig. 3 Q, S, T), and 24 hours (Fig. 4K) following MI
groups and all sham operated groups. In 60 minute (Fig. 3 M, O,
P), 4 hours (Fig. 3 Q, S, T), we noticed a decrease in the number
of cardiac myocytes that expresses HIF-1 a and most of the cells
that express HIF-1 a are endothelial cells. In 24 hours post MI
group the expression of HIF-1a is in the nuclei of few
cardiomyocytes and more endothelial cells in areas surrounding
the infarction while cardiomyocytes in the center of infarction does
not show any expression of HIF-1a (Fig. 4K). On the contrary,
many infiltrating neutrophil polymorphs in the center of infarction
show nuclear expression of HIF-1 a (Fig. 4K). As early as 60
minutes following MI we can identify an area of infarcted
cardiomyocytes that they do not express HIF-1 a (Fig. 3 M) this
area is more obvious at 4 hours (Fig. 3 Q) and 24 hours following
MI (Fig. 4K).
Figure 8. Galectin-1 expression 60 minutes following ligation of LAD. A& B, A low power view of the heart showing a high expression of
galectin-1 in the anterior wall of left ventricle in the area supplied by LAD (thin arrow) and the interventricular septum (thick arrow). There is also
increase in the expression of galectin-1 in the right ventricle (arrow head), streptavidin- biotin immunoperoxidase method. C. Sham operated heart
showing low expression of galectin-1 in the left ventricle and right ventricle (thin arrow), streptavidin- biotin immunoperoxidase method. D. Negative
control section of the heart showing absence of staining of galectin-1. E, F & G, Representative sections of the left ventricle from areas supplied by
LAD showing high cytoplasmic expression of galectin-1 by cardiac myocytes (thin arrow) surrounding areas of low or absence of expression (star
shape), streptavidin- biotin immunoperoxidase method. H, I& J, Representative section from left ventricle showing a well demarcated area of high
cytoplasmic expression of galectin-1 by cardiac myocytes (thin arrow), Alexa Fluor 488 immunofluorescent technique.
doi:10.1371/journal.pone.0086994.g008
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Galectin-1 in the Heart Tissue
GAL-1 concentration in LV tissue of naı̈ve group is
66.3264.69 ng/mg. GAL-1 concentration in LV tissue is signif-
icantly increased at 20 minutes (148.9166.65 vs.
117.2064.45 ng/mg P=0.001*) and 30 minutes (117.4563.49
vs 101.7962.63 ng/mg, P=0.004*) post MI groups compared to
corresponding sham operated control groups (Table 3) (Fig. 2
C). GAL-1 values at 60 minutes and 4 hours post MI groups are
higher than their corresponding sham operated control groups but
do not reach statistical significance (100.4363.05 vs
94.9962.76 ng/mg, P= 0.208 and 97.0163.31 vs
91.0763.26 ng/mg, P= 0.224). At 24-hour post MI group,
GAL-1 concentration in sham-operated control group is a bit
higher than its corresponding MI group (85.2462.42 ng/mg vs
75.7163.87) but shows no statistical significance. GAL-1 values in
LV in all MI groups are higher than the baseline naı̈ve control
group.
There was a statistically significant difference between the
different time points within the MI groups as determined by one-
way ANOVA (F (4,35) = 40.693, p= .000). A Tukey post-hoc test
revealed that the 20 minutes post MI GAL-1 level (M = 148.9,
95% CI [133.18, 164.6]) is significantly higher than the 30 minutes
(M = 117.4, 95% CI [109.2, 125.72], p= 0.00), 60 min-
utes(M = 100.43.9, 95% CI [93.22, 107.65], p= 0.00), 4 hour
(M = 97.01, 95% CI [89.18, 104.84], p= 0.00) and 24 hour post
MI group (M = 75.71, 95% CI [66.57, 84.86], p= 0.00 ). 30
minutes post MI GAL-1 value is also higher than the 4 hour
(p= 0.015), and 24 hours time point (p= 0.00). 30 minutes post MI
GAL-1 value is also higher than 60 minutes post MI group but not
reach statistical significance (p= 0.058). 60 minutes post MI group
value is significantly higher than the 24 hour MI group (p= 0.002)
and 4 hour MI level is significantly higher than 24 hour post MI
time point (p= 0.01).
In normal heart, GAL-1 is mainly seen to be expressed by
cardiomyocytes and endothelial cells (Fig. 5). The expression is
more pronounced in the right ventricle as compared to the left
ventricle (Figure 5 D, E, F). In the left ventricle, GAL-1 is mainly
expressed by endothelial cells and few cardiomyocytes (Fig. 5E).
A very characteristic staining pattern is seen in immunofluorescent
labeling of GAL-1, which gives a mesh-like staining pattern of
Figure 9. Galectin-1 expression 4 hours following ligation of LAD. A.A low power view of the heart showing a high expression of galectin-1
in the anterior wall of left ventricle in the area supplied by LAD (thin arrow) and the interventricular septum (thick arrow). There is also increase in the
expression of galectin-1 in the right ventricle (arrow head), streptavidin- biotin immunoperoxidase method. B. Sham operated heart showing low
expression of galectin-1 in the left ventricle (thin arrow) and right ventricle (arrow head), streptavidin- biotin immunoperoxidase method. C. Negative
control section of the heart showing absence of staining of galectin-1. D. Representative section of the left ventricle from area supplied by LAD
showing high cytoplasmic expression of galectin-1 by cardiac myocytes (thin arrow) surrounding areas of low or no expression (star shape),
streptavidin- biotin immunoperoxidase method. E&F, Representative section of the left ventricle from area supplied by LAD showing a well
demarcated area of high cytoplasmic expression of galectin-1 by cardiac myocytes (thin arrow), streptavidin- biotin immunoperoxidase method. G,
H&I. Representative section from left ventricle showing a well demarcated area of high cytoplasmic expression of galectin-1 by cardiac myocytes (thin
arrow) surrounding areas of low or no expression (star shape), Alexa Fluor 488 immunofluorescent technique.
doi:10.1371/journal.pone.0086994.g009
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Figure 10. Co-localization of Galectin-1 and HIF-1 a. A,D,G,J,M, Q show representative sections of the left ventricle from areas supplied by LAD
in 20 minutes(Low power view), 20 minutes(high power view), 30 minutes, 60 minutes, 4 hours and 30 minutes (High power view) following MI
respectively, showing high cytoplasmic expression of galectin-1 by cardiac myocytes (thin arrow), Alexa Fluor 488 immunofluorescent technique.
B,E,H,K,N,W show representative sections of the left ventricle from areas supplied by LAD in 20 minutes(Low power view), 20 minutes(high power
view), 30 minutes, 60 minutes, 4 hours and 30 minutes (High power view) following MI respectively showing high nuclear expression of HIF-1a by
cardiac myocytes (thin arrow), Rhodamine immunofluorescent technique. C,F,I,L,P,X shows Co-localization of galectin-1 and HIF-1 a in the same
sections at the respective time points. (arrow head), Alexa Fluor-Rhodamine immunofluorescent technique.
doi:10.1371/journal.pone.0086994.g010
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Figure 11. Co-localization of Galectin 1, HIF-1 a, CD31, desmin and CD68. A,D,G, Representative section of the left ventricle from areas
supplied by LAD showing high cytoplasmic expression of galectin-1 by cardiac myocytes, endothelial cells and histiocytes respectively (thin arrows). J,
showing high cytoplasmic expression of CD68 in tissue histiocytes (thin arrows) and M showing high cytoplasmic expression of CD31 in endothelial
cells (thin arrows). Alexa Fluor 488 immunofluorescent technique. B. showing high cytoplasmic expression of desmin by cardiac myocytes (thin
arrow), E. showing high cytoplasmic expression of CD31 by endothelial cells (thin arrow), H. showing high cytoplasmic expression of CD68 by
histiocytes (thin arrow), K. showing high nuclear expression of HIF-1 a by histiocytes (thin arrow), N. showing high nuclear expression of HIF 1 a by
endothelial cells (thin arrow), Rhodamine, immunofluorescent technique. C. Co-localization of galectin-1 and desmin in cardiac myocytes. F. Co-
localization of galectin-1 and CD31 in endothelial cells (arrow head), I. Co-localization of galectin-1 and CD68 in histiocytes (arrow head), L. Co-
localization of CD68 and HIF-1 a in tissue histiocytes (arrow head), O. Co-localization of CD31 and HIF-1 a in endothelial cells (arrow head). Alexa Fluor
488-Rhodamine immunofluorescent technique.
doi:10.1371/journal.pone.0086994.g011
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myocardium (Fig. 5 G, H, I). There is an increase in the
expression of GAL-1 in the LV as compared with sham operated
heart sections. In MI groups, the expression of GAL-1 is well
demarcated in the area supplied by LAD artery at 24- hour, 20,
30, 60 minutes and 4- hour following MI (Fig. 4, 6, 7, 8 & 9
respectively). Both cardiac myocytes and endothelial cells show
high expression of GAL-1 (Fig. 6E, 7F, 8F, 9F). In addition,
there are foci of low or no expression of GAL-1 surrounded by
areas of high expression (Fig. 4, 6, 7, 8 & 9).The number of
cardiac myocytes that express GAL-1 is decreased as the time
following ligation is increased. This phenomenon is also seen but
to a lesser extent in endothelial cells. Hence, areas of low or no
expression of GAL-1 increase in size and become more
demarcated as we reach 4 hours and then 24 hours following
MI (Fig. 4 E, F, G & 9 D, E, F, G, H). In 24 hours post MI, the
GAL-1 expression is seen in areas surrounding the infarction
(Fig. 4 E, F, G, H& I). There is no expression of GAL-1 in the
dead cardiomyocytes hence, these areas are very sharply
demarcated (Fig. 4 E, F, G, H& I). Neutrophil polymorphs,
which are abundant at 24 hours post MI group, also show high
expression of GAL-1 (Fig. 4 G& H). GAL-1 show many patterns
of staining in the heart at different time points following MI which
include diffuse cytoplasmic staining (Fig. 7 G& I), Z bands
staining (Fig. 6H), cell membrane staining (Fig. 5 G, H, I and
Fig. 10Q) and nuclear staining (Fig. 6 E&F).
Galectin-1 Levels in Plasma
Plasma GAL-1 concentration in naı̈ve group is 8.7160.83 ng/
ml. Plasma GAL-1 concentration is significantly raised at 4 hours
(15.0561.09 vs 9.9161.35 ng/ml, P=0.012*) and 24 hours
(22.5960.42 vs 17.8660.93 ng/ml, P=0.001*) post MI groups
compared to corresponding sham operated control groups (Fig. 2
D). Plasma GAL-1 values at 30 minutes and 60 minutes post MI
groups are not significantly different from their corresponding
sham-operated control groups (15.4961.29 vs 14.0660.78 ng/ml
and 14.2760.72 vs 13.3361.49 ng/ml).
Co-localization of Galectin-1 and HIF-1 a
Co-localization of GAL-1 and HIF-1 a in cardiomyocytes and
endothelial cells is shown in Fig. 10. All cardiac myocytes that
show nuclear expression of HIF-1 a also express GAL-1 in the
cytoplasm and some nuclei. All endothelial cells that show nuclear
expression of HIF-1 a also express GAL-1 in the cytoplasm and
some nuclei. GAL-1 expression in cardiomyocytes is confirmed by
co-localizing it with Desmin Fig. 11 C. GAL-1 and HIF-1 a
expression in endothelial cells is shown with co-localization with
CD31 (Fig. 11F&O respectively). Few tissue histiocytes, which
express CD68, also show co-localization with GAL-1 and HIF-1 a
(Fig. 11 I& L respectively). In general, few tissue histiocytes are
noticed during the first 24 hours following MI.
Morphometric Analysis
The frequency of cardiomyocytes expressing GAL-1 in 20 and
30 minutes post MI group is higher than other MI groups and
show statistically significance when compared with 24-hour post
MI group (Chi squared = 6.779 with 1 degree of freedom.
P = 0.009* and Chi squared = 9.968 with 1 degree of freedom.
P = 0.001*, respectively). The frequency of endothelial cells
expressing GAL-1 in 20 is higher than other MI groups and
shows statistical significance when compared with 60 minutes, 4-
hour and 24-hour post MI groups (Chi squared = 4.282 with
1 degree of freedom. P = 0.03*, Chi squared = 6.627 with
1 degree of freedom. P = 0.01*, Chi squared = 9.29 with 1 degree
of freedom. P = 0.002*, respectively). The frequency of endothelial
cells expressing GAL-1 in 30 minutes post MI group is significantly
higher than 24-hour post MI groups (Chi squared = 3.931 with
1 degree of freedom. P = 0.047*). The frequency of cardiomyo-
cytes expressing HIF-1 a in 20 minutes post MI group is
significantly higher than 30 minutes, 60 minutes, 4-hour and 24-
hour post MI groups (Chi squared = 9.158 with 1 degree of
freedom. P = 0.002*, Chi squared = 34.1 with 1 degree of
freedom. P = 0.0001*, Chi squared = 57.001 with 1 degree of
freedom. P = 0.0001*, Chi squared = 84.5 with 1 degree of
freedom. P = 0.0001*, respectively). The frequency of endothelial
cells expressing HIF-1 a in 20 minutes post MI group is
significantly higher than 30 minutes, 60 minutes, 4-hour and 24-
hour post MI groups (Chi squared = 12.3 with 1 degree of
freedom. P = 0.0004*, Chi squared = 36.5 with 1 degree of
freedom. P = 0.0001, Chi squared = 49.1 with 1 degree of
freedom. P = 0.0001, Chi squared = 54.3 with 1 degree of
freedom. P = 0.0001*, respectively). The frequency of endothelial
cells expressing GAL-1 is significantly higher than cardiomyocytes
at 20 minutes, 30 minutes, 60 minutes, 4-hour and 24-hour post
MI groups (Chi squared = 42.4 with 1 degree of freedom.
P = 0.0001*, Chi squared = 25.9 with 1 degree of freedom.
P = 0.0001*, Chi squared = 31.1 with 1 degree of freedom.
P = 0.0001*, Chi squared = 34.3 with 1 degree of freedom.
P = 0.0001*, Chi squared = 38.8 with 1 degree of freedom.
P = 0.0001*, respectively). The frequency of endothelial cells
expressing HIF-1 a is significantly higher than cardiomyocytes at
4-hour and 24-hour post MI groups (Chi squared = 6.84 with 1
degree of freedom. P = 0.008* and Chi squared = 17.04 with 1
degree of freedom. P = 0.0001*, respectively). The frequency of
neutrophil polymorphs expressing GAL-1 is significantly higher
than cardiomyocytes and endothelial cells at 24-hour post MI
groups (Chi squared = 69.8 with 1 degree of freedom. P = 0.0001*
Table 4. Morphometric analysis of expression of GAL-1 and HIF-1a in cardiomyocytes, endothelial cells and neutrophil
polymorphs at different time points following ligation of LAD.
POST MI GALECTIN -1 HIF-1a
TIME POINTS Cardiomyocytes % Endothelial cells % Neutrophils % Cardiomyocytes % Endothelial cells % Neutrophils %
20 MINUTES 49 92 0 83 94 0
30 MINUTES 53 87 0 63 75 0
60 MINUTES 41 81 0 42 56 0
4 HOURS 36 78 0 29 48 0
24 HOURS 30 75 89 17 45 82
doi:10.1371/journal.pone.0086994.t004
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and Chi squared = 5.72 with 1 degree of freedom. P = 0.016*,
respectively). The frequency of neutrophil polymorphs expressing
HIF-1 a is significantly higher than cardiomyocytes and endothe-
lial cells at 24-hour post MI groups (Chi squared = 81.9 with 1
degree of freedom. P = 0.0001* and Chi squared = 27.9 with 1
degree of freedom. P = 0.0001*, respectively). A decrease in the
Figure 12. Ki-67 proliferative activity in the left ventricle. A, B, C, D, Low Ki-67 proliferative activity in normal left ventricle showing nuclear
staining of Ki-67 in one interstitial cell (arrow head). E, F, G, 20 minutes MI; I,J, K, 30 minutes MI; M,N,O 60 minutes MI; Q,R,S, 4-hour MI, Low Ki-67
proliferative activity: showing nuclear staining of Ki-67 in few endothelial cells (arrow head) in left ventricle. U, V, W, 24-hour MI, high Ki-67
proliferative activity showing nuclear staining of Ki-67 in a large number of endothelial cells (arrow head) in the infarction area of left ventricle. H, L, P,
T, X, showing faint nuclear staining of Ki-67 in one endothelial cell in 20 minutes, 30 minutes, 60 minutes, 4-hours and 24 hour sham-operated left
ventricle. A, E, I, M, Q, U are stained by Streptavidin-Biotin immunoperoxidase method. The others are stained by Alexa Fluor 488 immunofluorescent
technique.
doi:10.1371/journal.pone.0086994.g012
Galectin-1 in Early Myocardial Infarction
PLOS ONE | www.plosone.org 15 January 2014 | Volume 9 | Issue 1 | e86994
number of cardiomyocytes and endothelial cells that express GAL-
1 and HIF-1 a is associated with the increase in post MI time.
Neutrophil polymorphs were counted at 24-hour following MI as
they are not seen before 4 hour post MI time (Table 4).
Proliferation and Apoptosis in Early Post Myocardial
Infarction
Our staining with Ki-67 showed that there is a low proliferative
activity in 20 minutes, 30 minutes, 60 minutes and 4-hour post MI
sections. (Figure 12), but in 24 hours post MI sections we are
able to see clearly an increase in the expression of Ki-67 in the
endothelial cells in the area of infarction (Figure 12 U&V) while
the relevant sham operated sections show very low expression of
Ki-67 (Figure 12 X).
We also found that there is very low expression of caspase-3 and
cleaved caspase-3 at 30 minutes, 60 min and 4 hours time points
(Figure 13 D, E, F). At 24- hour post MI group however, we do
find increase in the expression of caspase-3 and cleaved caspase-3
activity (Figure 13 A, C), compared to the sham group
(Figure 13 B). The expression of caspase-3 and cleaved caspase
3 was seen in cardiac myocytes and endothelial cells in the area of
infarction. Many apoptotic bodies, expressing cleaved caspase-3,
are seen in the area of infarction (Figure 13 C).
Bcl-2 expression is increased in the 30 minutes post infarction
time in the LV in the area of infarction of the left ventricle
(Figure 14 A–D). Its expression is seen in the cardiomyocytes and
endothelial cells; however, the expression in the endothelial cells is
considerably greater than the cardiomyocytes. Sham group
showed faint staining of bcl-2 and only in the endothelial cells.
Bioinformatic Analysis Results
The output from the clustalw2 program is shown in Fig. 15.
We found at least 4 potential HREs in the promoter region of
Figure 13. Apoptotic activity in the left ventricle. A. showing high expression of caspase- 3 in cardiac myocytes (arrow head) surrounding the
necrotic area, endothelial cells (thin arrow), and neutrophil polymorphs (thick arrow) in 24-hour post MI, Alexa Fluor 488 immunofluorescent
technique. B. showing no expression of caspase 3 in 24-hour sham-operated left ventricle. C, showing high expression of cleaved caspase- 3 in cardiac
myocytes (thick arrows). Many apoptotic bodies (arrow head) are seen in the infarcted area of left ventricle, streptavidin- biotin immunoperoxidase
method. D, showing very low apoptotic activity, only one cell stained with anti-cleaved caspase 3 (arrow head) in the area of infraction in the left
ventricle of 4-hour post MI, streptavidin- biotin immunoperoxidase method. E, F, Showing no staining with anti-cleaved caspase 3 in the left ventricle
of 30 minutes and 60 minutes post MI, streptavidin- biotin immunoperoxidase method.
doi:10.1371/journal.pone.0086994.g013
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Human GAL-1 gene (Fig. 15 A & B) and potential HRE’s in the
promoter region of mouse GAL-1 gene (Fig. 15 C&D).
Discussion
Galectins are highly conserved, from fungi to mammals with
their existence dating back to more than 800 million years. This
suggests that these endogenous proteins must be serving an
important purpose [31–33]. Although GAL-1 knockout mice fail
to show any abnormalities [11], but knocking down GAL-1-like
protein in the zebrafish shows defects in muscle development and
disorganized muscle fibers [34]. There is also evidence that GAL-1
has a significant role in the regeneration of muscles [35–37].
GAL-1 is endogenous to the heart. The level of expression in
cardiomyocytes is among the highest compared to other organs of
the body [38]. In accordance with a previous report [38], our
immunohistochemistry and immunoflorescence staining of heart
sections show that it is expressed in cardiac muscles as diffuse
cytoplasmic staining, as an organized Z bands staining, as a
membranous staining and as nuclear staining.
Acute MI in our mice model shows increase in the level of GAL-
1 in the LV at a very early stage in the course of event. We show a
significant increase in LV tissue GAL-1 levels at 20 minutes and 30
minutes following MI as compared to related sham operated
control groups. The values at 60 minutes and 4 hours are also
higher than their corresponding sham operated control groups but
do not reach statistical significance (Figure 2 C). These results
show that there is a transient rise in the GAL-1 level in the LV
within one hour of permanent ligation of LAD. This is supported
by one-way ANOVA and Tukey post-hoc test analysis of MI
groups which shows GAL-1 values at 20 and 30 minutes MI group
are significantly higher than other MI groups.
The immunohistochemical and immunofluorescent staining
patterns for GAL-1 in cardiac muscles are also very characteristic
and supportive of this finding. The increased expression of GAL-1
in the LV is very well demarcated in the MI group in all tested
time points. We also noticed that as the time of ischemia increases
from 20 min to 4 hours and then 24 hours we are able to
recognize areas of low or no expression of GAL-1 being
surrounded by areas of high expression of GAL-1. The well
Figure 14. Bcl2 activity in left ventricle. A, B, C, D, showing high cytoplasmic expression of bcl2 by cardiac myocytes (thick arrow), and
endothelial cells (arrow head) at 30 minutes post MI in an area supplied by LAD in the left ventricle, streptavidin- biotin immunoperoxidase method.
E, F, showing very low expression of bcl2 in few endothelial cells (arrow head) in the left ventricle of naı̈ve and 30-minutes sham operated heart.
Streptavidin- biotin immunoperoxidase method.
doi:10.1371/journal.pone.0086994.g014
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demarcated areas of no or low expression of GAL-1 is increased as
the time of ischemia increases which mean that as time proceed
dying cells will stop expression of GAL-1 in the area supplied by
LAD, while survived cells in the ischemic zone, which are seen at
the periphery of infarction zone, are showing high expression of
GAL-1; which might explain the absence of statistical significance
at 60 minutes, 4-hour and 24-hour post MI time points when
compared to corresponding sham operated control groups. This is
supported by our morphometric analysis which shows a significant
decrease in the frequency of cardiomyocytes and endothelial cells
that express GAL-1 with the increase of post MI time.
This phenomenon is clearly seen in 24 hours post MI sections
(Fig. 4 E, F, G, H, &I) where GAL-1 is observed to be high in
the surviving cardiomyocytes and invading neutrophil polymorphs
in the immunohistochemical and immunofluorescent- stained
sections, while dead cells in the infarction zone do not show any
expression which explains the absence of statistical significance in
our ELISA results at this time point.
GAL-1 has been reported to be up regulated in tumors under
hypoxic conditions [20]. It also plays a role in chronic hypoxia in
the lung [22], and has shown to be important in cerebral, lung and
renal ischemic events [21,22,39,40]. One recent study reported
raised GAL-1 levels in HL-1 cardiomyocytes exposed to hypoxic
environment [41]. The same study also showed raised GAL-1
concentration in the hearts of mice after 7 days of undergoing
experimental acute myocardial infarction emphasizing on its role
in the post infarction remodeling of the heart [41]. They have
suggested a protective role for GAL-1 through its negative
regulation of the heart’s inflammatory response. We report for
the first time that GAL-1 is elevated in the LV very early following
acute myocardial infarction. The first 4 hours post MI is the time
before inflammatory cells particularly neutrophil polymorphs flood
the infarcted area of the heart [42]. So the changes observed till 4-
hour post MI are not due to the effect of invading inflammatory
cells but predominantly due to hypoxia/ischemia related factors,
while the changes at 24 hours following MI time can be a
combination of inflammatory and hypoxia/ischemia related
players.
HIF-1 a levels in the LV also shows a significant increase in 20
minutes post MI group compared to sham operated control group
(Fig. 2 A&B). In addition, HIF-1 a value in the MI groups at 30
minutes, 1 hour and 4 hours are higher than corresponding sham
operated control groups but shows no statistical significance. This
is supported by one-way ANOVA and Tukey post-hoc test analysis
of MI groups which shows HIF-1 a value at 20 minutes MI group
is significantly higher than other MI groups. Moreover, HIF-1 a
values in all MI groups is higher than the baseline non-operated
naı̈ve control groups. We show for the first time a transient peak in
LV HIF-1 a level at 20 minutes following MI, which goes down
afterwards.
The immunohistochemical and immunofluorescent staining
results are very characteristic and supportive of this pattern
(Fig. 3).
We know that HIF-1 a is a heterodimeric DNA-binding
complex composed of constitutively expressed HIF-1b or aryl
hydrocarbon nuclear translocator and the oxygen sensitive
hypoxia-inducible HIF-1a [43]. Under normoxic conditions
HIF-1a subunit has a very short half-life [44] and is continuously
undergoing proteasomal degradation. During hypoxia, HIF-1a
protein escapes proteasomal degradation, translocates to the
nucleus and dimerizes with HIF-1b. This complex then binds to
the HRE in promoter or enhancer sequences of target genes [45]
and results in their transcription.
We believe that in our experiments, initial increase in HIF-1 a
levels in the LV is due to stabilization of HIF-1 a as a result of low
intracellular level of oxygen secondary to complete ligation of
LAD artery. We also observe a decrease in LV level of HIF-1 a as
the time of ischemia increased. We think that as the time of
ischemia increases the cardiomyocytes become necrotic and HIF-1
a level go down due to protein degradation. As mentioned in the
methods section, we took only the LV protein extraction, so the
mass of heart tissue is more or less similar between samples. If the
cells in the middle of the infarct are necrotic and HIF- 1 a is
degraded as the time of ischemia increases then it is understand-
able that the levels of HIF-1 a in the 1 hour, 4 hour and 24 hour
post MI groups are not significantly higher than corresponding
sham operated groups.
HIF-1 a is being expressed by the nuclei of cardiomyocytes and
endothelial cells follows the same pattern seen in immunohisto-
chemical and immunofluorescent-stained sections and we are able
to see that as the time of ischemia increases the number of cells
with high expression of HIF-1 a is decreased. This is supported by
Figure 15. Potential HREs in the promoter region of galectin-1 gene. A, Human GAL-1 promoter with consensus sequence ACGTG (-1075). B,
Human GAL-1 promoter with consensus sequence CACGC (2519, 2533, 2935). C, Mouse GAL-1 promoter with consensus sequence NCGTG (2978).
D, Mouse GAL-1 promoter with consensus sequence TGCAC (2640).
doi:10.1371/journal.pone.0086994.g015
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our morphometric analysis which shows a significant decrease in
the frequency of cardiomyocytes and endothelial cells that express
HIF-1 a with the increase of post MI time.
Another observation pertinent to HIF-1 a staining was that
while the expression of HIF-1 a decreases in cardiomyocytes as the
time of ischemia increases, its expression in endothelial cells
essentially remains the same. A possible explanation for this can be
related to the fact that endothelial cells are proliferating cells that
participate in healing process of the infarcted zone and in the
formation of collaterals while survived cardiomyocytes do not
proliferate. We think that when continuous ischemia damages the
cardiomyocytes its expression is lost but the surrounding
endothelial cells keep on proliferating and expressing HIF-1 a.
HIF-1 a is a protective factor that mediates the survival of
injured cardiomyocytes in the setting of ischemic injury by
transcribing a variety of cardioprotective genes including erythro-
poietin, vascular endothelial growth factor, inducible nitric oxide
synthase, hemeoxygenase-1 and cardiotropin [46].
In Fig. 10 and 11, we show co-localization of GAL-1 and HIF-
1 a in cardiac myocytes and endothelial cells in LV sections from
areas supplied by LAD at different time points in the first 4 hours
following MI. Cardiomyocytes and endothelial cells that show
nuclear expression of HIF-1 a also show cytoplasmic and nuclear
expression of GAL-1, while cells that do not express HIF-1 a they
also show no expression of GAL-1, which might indicate a possible
correlation in the expression of both proteins. In Fig. 4 K, L, M,
we are able to show co-expression of GAL-1 and HIF-1 a in
surviving cardiomyocytes and endothelial cells at the periphery of
infarction zone while dead cardiomyocytes in the centre of
infarction do not show any expression, which might also support a
possible correlation between both proteins. In the same figure, we
are also able to show co-expression of GAL-1 and HIF-1 a by
neutrophil polymorphs that infiltrate the myocardium following
MI to digest dead cells and facilitate their removal at a later time
by macrophages. Those neutrophil polymorphs are moving in
between dead cells in the ischemic zone, so they are expected to be
under hypoxic condition; therefore they are expressing HIF-1 a; as
hypoxia can stabilize HIF-1 a and prevents its proteasomal
degradation. At the same time, we notice those invading
neutrophil polymorphs are also expressing GAL-1, which might
also support a possible correlation.
In Fig. 2 E, we show the pattern of GAL-1 and HIF-1 a in the
heart from 20 minutes till 24 hours post MI time points. It shows
both proteins follow the same pattern in the first 24 hours
following MI and their co-localization seen by immunofluorescent
staining further supports our idea that GAL-1 is a possible
transcriptional target of HIF-1 a in the heart at least in the early
period after MI.
We also found potential HRE’s in the promoter region of GAL-
1 through bioinformatics analysis (Fig. 15). This is supported by a
previous study [23], which also showed that there are seven
potential HREs within 2.2 kb region upstream the transcriptional
start site of GAL-1. Experimental evidence also exists of GAL-1
being a transcriptional target of HIF-1 a [23].
We suggest that in our experiment, GAL-1 gene transcription
by HIF-1 a can lead to increased expression of GAL-1 in
cardiomyocytes, which might also prove to be cardioprotective
due to its anti-inflammatory properties [47,48]. As the time of
ischemia increases, cells in the centre of the infarct loose HIF-1 a
and consequently GAL-1 while the surrounding surviving cells
express high levels of HIF-1 alpha and subsequent GAL-1 to limit
damage and prevent further injury.
To further look into the biological role underlying the early
expression of GAL-1 and HIF-1 a in cardiomyocytes, we looked at
the pro-apoptotic and anti-apoptotic proteins at these early time
points. Pro-apoptotic caspase-3 and cleaved caspase-3 were found
to have a very low expression at early time points post MI, while in
24-hour post MI group the expression is increased in the area of
infarction compared to the sham operated group (Fig. 13).
Moreover, the anti-apoptotic Bcl-2 expression is high at early time
points, especially in 30 minutes post MI group, in the area of
infarction (Fig. 14). As we can see that in the early post MI time
points there is predominantly antiapoptotic activity in the left
ventricle which correlates with the high tissue GAL-1 and HIF-1 a
levels at that time. While in 24-hour post MI time point we have
high apoptotic activity which correlates with low tissue levels of
GAL-1 and HIF-1 a at that time. This further supports our
concept that GAL-1 and HIF-1 a are part of the prosurvival mode
of action of the cell after ischemic insult at least in the early
myocardial infarction time.
We also found that in the early post MI time there is low
proliferative activity in the LV (Fig. 12), so we are unable to
comment on any proliferative role of GAL-1 and HIF-1 a at these
time points. While in 24-hour post MI group there is an increase in
the proliferative activity of endothelial cells around the area of
infarction (Fig. 12 U&V) as part of the attempts to increase
vascularity in the ischemic area to overcome low perfusion as well
as participating in the healing process [49].
Another significant finding of our study is that GAL-1 plasma
level is significantly high around 4 hours and 24 hours post MI
compared to sham operated control mice (Fig. 2 D).
There can be two possible explanations for this phenomenon.
We know that GAL-1 is present in the heart tissue in significant
amount, acute myocardial infarction and subsequent cell mem-
brane damage and necrosis promotes its leakage outside the cells
into the blood. This phenomenon is similar to the raised
Troponin-I protein [50] that escapes the injured cardiomyocytes
and can be detected in the blood. The other explanation for raised
plasma levels is that GAL-1 in heart tissue is increased in early
ischemic period due to increased transcriptional pressure from
HIF-1 a and is secreted from the heart through the non-classical
pathway. We think that plasma GAL-1 levels in the first hour post
MI signify increase in transcription of the protein and leakage
from the cells, whereas, at 4 hours and 24 hours post MI, the high
GAL-1 plasma levels is mainly due to leakage of this protein from
cardiomyocytes.
We have observed in our study that the levels of GAL- 1 and
HIF-1 a in sham operated animals were higher than the non-
operated naı̈ve animals. This increase in sham operated animals
can be due to factors related to surgical stress. There have been
reports in scientific literature that there is stress-induced increase
of GAL- 1 in serum which is regulated by the sympathetic nervous
system [51]. Another study [52] demonstrated that HIF-1 a
protein in the myocardium can be induced by mechanical stress to
the heart. As there is some degree of mechanical/surgical stress
applied to the sham operated mice we can suggest that GAL-1 and
HIF-1 a levels seen in sham group may be the result of these
factors.
For these reasons we make sham operated groups as our
controls for all time points, and all our statistics were done in
comparison between MI groups and sham-operated groups to take
out the effect of mechanical/surgical stress from the real ischemic
effect due to ligation of LAD. In all early MI groups the values of
GAL-1 and HIF-1 are higher than corresponding sham groups
and show statistical significance at certain time points. So the
significant rise of GAL-1 and HIF-1 a levels at certain time points
in MI groups when compared to sham-operated groups is purely
due to ischemia and not surgical stress.
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Conclusions
We show for the first time that GAL-1 level in the LV is
increased in early ischemic period which can possibly be a part of
the prosurvival gene expression profile transcribed by HIF-1 a.
We also report for the first time that HIF-1 a is significantly
increased at 20 minutes following myocardial infarction. In
addition, we report for the first time that in mouse model of
myocardial infarction plasma GAL-1 level is significantly raised as
early as 4 hours of the event.
The study is significant because it can help in understanding the
very early changes that occur in the myocardium after acute
infarction and help devise ways to diagnose early and save the
viable tissue before permanent damage sets in. Raised plasma
GAL-1 levels in this early phase of infarction in the mice is
significant in terms of its potential use as a biomarker for MI, but
further studies are still needed to elaborate on its role.
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